Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice

Molecular Nutrition and Food Research

Volumn 60, Issue 2, 2016, Pages 300-312

  Kobori, Masuko ^a   Takahashi, Yumiko ^a   Sakurai, Mutsumi ^a   Akimoto, Yukari ^a   Tsushida, Tojiro ^b   Oike, Hideaki ^a   Ippoushi, Katsunari ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

^b MIYAGI UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Inflammation; Obesity; Oxidative stress; Quercetin

Indexed keywords

ANTIOXIDANT; ENZYME; QUERCETIN;

ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; IMMUNOLOGY; LIPID DIET; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; METABOLIC SYNDROME X; METABOLISM; MITOCHONDRIAL GENE; MOUSE MUTANT; OBESITY;

ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; DIET, HIGH-FAT; ENZYMES; GENE EXPRESSION REGULATION; GENES, MITOCHONDRIAL; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; METABOLIC SYNDROME X; MICE, INBRED C57BL; MICE, OBESE; OBESITY; QUERCETIN;

EID: 85000351067     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500595     Document Type: Article

References (45)

1. Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H. et al., Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76, 560-568.
2. Peterson, J. J., Dwyer, J. T., Jacques, P. F., McCullough, M. L., Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr. Rev. 2012, 70, 491-508.
3. Nishimuro, H., Ohnishi, H., Sato, M., Ohnishi-Kameyama, M. et al., Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients 2015, 7, 2345-2358.
4. Kobori, M., Masumoto, S., Akimoto, Y., Takahashi, Y., Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 2009, 53, 859-868.
5. Kobori, M., Masumoto, S., Akimoto, Y., Oike, H., Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol. Nutr. Food Res. 2011, 55, 530-540.
6. Huh, J. Y., Park, Y. J., Ham, M., Kim, J. B., Cross-talk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol. Cells 2014, 37, 365-371.
7. Nishimura, S., Manabe, I., Nagasaki, M., Eto, K. et al., CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15, 914-920.
8. Wensveen, F. M., Jelencic, V., Valentic, S., Sestan, M. et al., NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 2015, 16, 376-385.
9. Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R. et al., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271, 665-668.
10. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y. et al., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 2001, 7, 941-946.
11. Edgar, R., Domrachev, M., Lash, A. E., Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30, 207-210.
12. Kobori, M., Takahashi, Y., Akimoto, Y., Sakurai, M. et al., Chronic high intake of quercetin reduces oxidative stress and induces expression of the antioxidant enzymes in the liver and visceral adipose tissues in mice. J. Funct. Foods 2015, 15, 551-560.
13. Ruan, H., Hacohen, N., Golub, T. R., Van Parijs, L. et al., Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory. Diabetes 2002, 51, 1319-1336.
14. Piya, M. K., McTernan, P. G., Kumar, S., Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin. J. Endocrinol. 2013, 216, T1-T15.
15. Barnes, P. J., Karin, M., Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 1997, 336, 1066-1071.
16. Zhuang, G., Meng, C., Guo, X., Cheruku, P. S. et al., A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation 2012, 125, 2892-2903.
17. Su, G. H., Ip, H. S., Cobb, B. S., Lu, M. M. et al., The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J. Exp. Med. 1996, 184, 203-214.
18. Deng, T., Lyon, C. J., Minze, L. J., Lin, J. et al., Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 2013, 17, 411-422.
19. O'Rourke, R. W., White, A. E., Metcalf, M. D., Winters, B. R. et al., Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metab. Clin. Exp. 2012, 61, 1152-1161.
20. Ventre, J., Doebber, T., Wu, M., MacNaul, K. et al., Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 1997, 46, 1526-1531.
21. Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K. et al., Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008, 103, 467-476.
22. Winer, D. A., Winer, S., Shen, L., Wadia, P. P. et al., B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17, 610-617.
23. Liu, J., Divoux, A., Sun, J., Zhang, J. et al., Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15, 940-945.
24. Stefanovic-Racic, M., Yang, X., Turner, M. S., Mantell, B. S. et al., Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 2012, 61, 2330-2339.
25. Talukdar, S., Oh da, Y., Bandyopadhyay, G., Li, D. et al., Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18, 1407-1412.
26. Xie, C., Turley, S. D., Dietschy, J. M., Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc. Natl. Acad. Sci. USA 1999, 96, 11992-11997.
27. Wang, M. Y., Orci, L., Ravazzola, M., Unger, R. H., Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc. Natl. Acad. Sci. USA 2005, 102, 18011-18016.
28. Horrillo, R., Gonzalez-Periz, A., Martinez-Clemente, M., Lopez-Parra, M. et al., 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity. J. Immunol. 2010, 184, 3978-3987.
29. van Greevenbroek, M. M., Ghosh, S., van der Kallen, C. J., Brouwers, M. C. et al., Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J. Clin. Endocrinol. Metab. 2012, 97, 4742-4752.
30. Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M. et al., Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58, 2574-2582.
31. Kawai, Y., Saito, S., Nishikawa, T., Ishisaka, A. et al., Different profiles of quercetin metabolites in rat plasma: comparison of two administration methods. Biosci. Biotechnol. Biochem. 2009, 73, 517-523.
32. Santos, M. R., Rodriguez-Gomez, M. J., Justino, G. C., Charro, N. et al., Influence of the metabolic profile on the in vivo antioxidant activity of quercetin under a low dosage oral regimen in rats. Brit. J. Pharmacol. 2008, 153, 1750-1761.
33. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M. et al., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 2004, 114, 1752-1761.
34. Houstis, N., Rosen, E. D., Lander, E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440, 944-948.
35. Bondia-Pons, I., Ryan, L., Martinez, J. A., Oxidative stress and inflammation interactions in human obesity. J. Physiol. Biochem. 2012, 68, 701-711.
36. Patti, M. E., Corvera, S., The role of mitochondria in the pathogenesis of type 2 diabetes. Endocrine Rev. 2010, 31, 364-395.
37. Kusminski, C. M., Scherer, P. E., Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol. Metab. 2012, 23, 435-443.
38. Choo, H. J., Kim, J. H., Kwon, O. B., Lee, C. S. et al., Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006, 49, 784-791.
39. Ryu, M. J., Kim, S. J., Kim, Y. K., Choi, M. J. et al., Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. PLoS Genet. 2013, 9, e1003356.
40. Fullerton, M. D., Steinberg, G. R., SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 2010, 59, 551-553.
41. Dong, J., Zhang, X., Zhang, L., Bian, H. X. et al., Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKalpha1/SIRT1. J. Lipid Res. 2014, 55, 363-374.
42. Kleiner, S., Mepani, R. J., Laznik, D., Ye, L. et al., Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues. Proc. Natl. Acad. Sci. USA 2012, 109, 9635-9640.
43. Xu, M., Hu, J., Zhao, W., Gao, X. et al., Quercetin differently regulates insulin-mediated glucose transporter 4 translocation under basal and inflammatory conditions in adipocytes. Mol. Nutr. Food Res. 2014, 58, 931-941.
44. Shen, Y., Croft, K. D., Hodgson, J. M., Kyle, R. et al., Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK. Biochem. Pharmacol. 2012, 84, 1036-1044.
45. Lemonnier, D., Effect of age, sex, and sites on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet. J. Clin. Invest. 1972, 51, 2907-2915.